In line with this, the upregulation of leptin and its receptor have been associated with early stages of carcinogenesis, particularly in patients with in situ ductal carcinoma compared with invasive breast carcinoma, suggesting that leptin and its receptor can promote the breast tumour progression [117]. Here, LEP is linked to breast neoplasm.